{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T09:40:12Z","timestamp":1716198012173},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00405-013-2826-0","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T05:19:33Z","timestamp":1385356773000},"page":"2781-2787","source":"Crossref","is-referenced-by-count":1,"title":["The up-regulation expression of APRIL is a marker of glottic malignant disease"],"prefix":"10.1007","volume":"271","author":[{"given":"Meng","family":"Lian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jugao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"issue":"2","key":"2826_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/iub.417","volume":"63","author":"H Wu","year":"2011","unstructured":"Wu H, Liu T, Wang R et al (2011) MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2. IUBMB Life 63(2):101\u2013108","journal-title":"IUBMB Life"},{"issue":"7","key":"2826_CR2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/lary.20888","volume":"120","author":"SA Fleskens","year":"2010","unstructured":"Fleskens SA, van der Laak JA, Slootweg PJ et al (2010) Management of laryngeal premalignant lesions in the Netherlands. Laryngoscope 120(7):1326\u20131335","journal-title":"Laryngoscope"},{"issue":"18","key":"2826_CR3","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.ejca.2010.07.047","volume":"46","author":"J Ren","year":"2010","unstructured":"Ren J, Zhu D, Liu M et al (2010) Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of laryngeal squamous cell carcinoma. Eur J Cancer 46(18):3409\u20133416","journal-title":"Eur J Cancer"},{"issue":"4","key":"2826_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.otc.2008.01.019","volume":"41","author":"M Loyo","year":"2008","unstructured":"Loyo M, Pai SI (2008) The molecular genetics of laryngeal cancer. Otolaryngol Clin North Am 41(4):657\u2013672","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"2826_CR5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","volume":"188","author":"M Hahne","year":"1998","unstructured":"Hahne M, Kataoka T, Schr\u00f6ter M et al (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188(6):1185\u20131190","journal-title":"J Exp Med"},{"issue":"21","key":"2826_CR6","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1093\/emboj\/cdf565","volume":"21","author":"B Pradet-Balade","year":"2002","unstructured":"Pradet-Balade B, Medema JP, Lo\u2019pez-Fraga M et al (2002) An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK\u2013APRIL fusion protein. EMBO J 21(21):5711\u20135720","journal-title":"EMBO J"},{"key":"2826_CR7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000082107","volume":"8","author":"DF Jelinek","year":"2005","unstructured":"Jelinek DF, Darce JR (2005) Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors. Curr Dir Autoimmun 8:266\u2013288","journal-title":"Curr Dir Autoimmun"},{"issue":"4","key":"2826_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/s10165-011-0539-z","volume":"22","author":"T Furuya","year":"2012","unstructured":"Furuya T, Koga M, Hikami K et al (2012) Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL. Mod Rheumatol 22(4):541\u2013549","journal-title":"Mod Rheumatol"},{"issue":"5","key":"2826_CR9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/kem019","volume":"46","author":"A Kawasaki","year":"2007","unstructured":"Kawasaki A, Tsuchiya N, Ohashi J et al (2007) Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese. Rheumatology (Oxford) 46(5):776\u2013782","journal-title":"Rheumatology (Oxford)"},{"key":"2826_CR10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-9-83","volume":"9","author":"J Moreaux","year":"2009","unstructured":"Moreaux J, Veyrune JL, De Vos J et al (2009) APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer 9:83","journal-title":"BMC Cancer"},{"issue":"16\u201317","key":"2826_CR11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.clinbiochem.2009.06.019","volume":"42","author":"W Ding","year":"2009","unstructured":"Ding W, Wang J, Sun B et al (2009) APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Clin Biochem 42(16\u201317):1694\u20131698","journal-title":"Clin Biochem"},{"issue":"9","key":"2826_CR12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20042309","volume":"201","author":"K Ingold","year":"2005","unstructured":"Ingold K, Zumsteg A, Tardivel A et al (2005) Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201(9):1375\u20131383","journal-title":"J Exp Med"},{"issue":"6","key":"2826_CR13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.cdd.4401647","volume":"12","author":"J Hendriks","year":"2005","unstructured":"Hendriks J, Planelles L, de Jong-Odding J et al (2005) Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 12(6):637\u2013648","journal-title":"Cell Death Differ"},{"issue":"5","key":"2826_CR14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1096\/fj.08-124669","volume":"23","author":"FC Kimberley","year":"2009","unstructured":"Kimberley FC, van Bostelen L, Cameron K et al (2009) The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J 23(5):1584\u20131595","journal-title":"FASEB J"},{"issue":"3","key":"2826_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd1982","volume":"5","author":"SR Dillon","year":"2006","unstructured":"Dillon SR, Gross JA, Ansell SM et al (2006) An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5(3):235\u2013246","journal-title":"Nat Rev Drug Discov"},{"key":"2826_CR16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","volume":"68","author":"M Bernfield","year":"1999","unstructured":"Bernfield M, Gotte M, Park PW et al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729\u2013777","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"2826_CR17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"32","key":"2826_CR18","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","volume":"29","author":"C Jack","year":"2011","unstructured":"Jack C, Mitch D, Silvia P et al (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer. J Clin Oncol 29(32):4273\u20134278","journal-title":"J Clin Oncol"},{"issue":"5","key":"2826_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1590\/S1807-59322006000500008","volume":"61","author":"LL Matos","year":"2006","unstructured":"Matos LL, Stabenow E, Tavares MR et al (2006) Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics (Sao Paulo) 61(5):417\u2013424","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"2826_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ccr.2004.08.033","volume":"6","author":"L Planelles","year":"2004","unstructured":"Planelles L, Carvalho-Pinto CE, Hardenberg G et al (2004) APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 6(4):399\u2013408","journal-title":"Cancer Cell"},{"issue":"15","key":"2826_CR21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.ejca.2008.07.007","volume":"44","author":"P Mhawech-Fauceglia","year":"2008","unstructured":"Mhawech-Fauceglia P, Allal A, Odunsi K et al (2008) Role of the tumour necrosis family ligand APRIL in solid tumour development: retrospective studies in bladder, ovarian and head and neck carcinomas. Eur J Cancer 44(15):2097\u20132100","journal-title":"Eur J Cancer"},{"issue":"4","key":"2826_CR22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1189\/jlb.1105655","volume":"80","author":"P Mhawech-Fauceglia","year":"2006","unstructured":"Mhawech-Fauceglia P, Kaya G, Sauter G et al (2006) The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 80(4):697\u2013704","journal-title":"J Leukoc Biol"},{"key":"2826_CR23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1471-2407-9-434","volume":"9","author":"RD Petty","year":"2009","unstructured":"Petty RD, Samuel LM, Murray GI et al (2009) APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling. BMC Cancer 9:434","journal-title":"BMC Cancer"},{"issue":"21","key":"2826_CR24","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1182\/blood-2008-09-179762","volume":"113","author":"M Gupta","year":"2009","unstructured":"Gupta M, Dillon SR, Ziesmer SC et al (2009) A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood 113(21):5206\u20135216","journal-title":"Blood"},{"issue":"3","key":"2826_CR25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood-2010-01-264424","volume":"117","author":"J Quinn","year":"2011","unstructured":"Quinn J, Glassford J, Percy L et al (2011) APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. Blood 117(3):890\u2013901","journal-title":"Blood"},{"issue":"2","key":"2826_CR26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5603\/FHC.2012.0029","volume":"50","author":"E Jab\u0142o\u0144ska","year":"2012","unstructured":"Jab\u0142o\u0144ska E, Wawrusiewicz-Kurylonek N, Garley M et al (2012) TLR4 ligation induces expression of APRIL molecule in human neutrophils\u2014a preliminary study. Folia Histochem Cytobiol 50(2):196\u2013202","journal-title":"Folia Histochem Cytobiol"},{"issue":"1\u20132","key":"2826_CR27","first-page":"1","volume":"363","author":"J Wang","year":"2012","unstructured":"Wang J, Ding W, Sun B et al (2012) Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB\/c nude mice via APRIL siRNA. Mol Cell Biochem 363(1\u20132):1\u201310","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"2826_CR28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/cgt.2011.19","volume":"18","author":"F Wang","year":"2011","unstructured":"Wang F, Ding W, Wang J et al (2011) Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells. Cancer Gene Ther 18(7):500\u2013509","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"2826_CR29","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1102891","volume":"189","author":"G Notas","year":"2012","unstructured":"Notas G, Alexaki VI, Kampa M et al (2012) APRIL binding to BCMA activates a JNK2\u2013FOXO3\u2013GADD45 pathway and induces a G2\/M cell growth arrest in liver cells. J Immunol 189(10):4748\u20134758","journal-title":"J Immunol"},{"key":"2826_CR30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1471-2407-9-434","volume":"9","author":"RD Petty","year":"2009","unstructured":"Petty RD, Samuel LM, Murray GI et al (2009) APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling. BMC Cancer 9:434","journal-title":"BMC Cancer"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-013-2826-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2826-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T09:07:26Z","timestamp":1716196046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-013-2826-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2826"],"URL":"https:\/\/doi.org\/10.1007\/s00405-013-2826-0","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}